Is diabetic nephropathy disappearing from clinical practice?

被引:14
作者
Cooper, Mark E. [1 ]
机构
[1] Baker Med Res Inst, Melbourne, Vic 3004, Australia
关键词
D O I
10.1111/j.1399-5448.2006.00205.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:237 / 238
页数:2
相关论文
共 15 条
[1]  
ANDERSEN AR, 1983, DIABETOLOGIA, V25, P496
[2]   THE EFFECT OF PROTEINURIA ON RELATIVE MORTALITY IN TYPE-1 (INSULIN-DEPENDENT) DIABETES-MELLITUS [J].
BORCHJOHNSEN, K ;
ANDERSEN, PK ;
DECKERT, T .
DIABETOLOGIA, 1985, 28 (08) :590-596
[3]   Biochemistry and molecular cell biology of diabetic complications [J].
Brownlee, M .
NATURE, 2001, 414 (6865) :813-820
[4]   Should all patients with type 1 diabetes mellitus and microalbuminuria receive angiotensin-converting enzyme inhibitors? A meta-analysis of individual patient data [J].
Chaturvedi, N .
ANNALS OF INTERNAL MEDICINE, 2001, 134 (05) :370-379
[5]  
Collins R, 2003, LANCET, V361, P2005
[6]   Pathogenesis, prevention, and treatment of diabetic nephropathy [J].
Cooper, ME .
LANCET, 1998, 352 (9123) :213-219
[7]   Interaction of metabolic and haemodynamic factors in mediating experimental diabetic nephropathy [J].
Cooper, ME .
DIABETOLOGIA, 2001, 44 (11) :1957-1972
[8]   Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes [J].
Gaede, P ;
Vedel, P ;
Larsen, N ;
Jensen, GVH ;
Parving, H ;
Pedersen, O .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (05) :383-393
[9]   Predictors for the development of microalbuminuria and macroalbuminuria in patients with type 1 diabetes: inception cohort study [J].
Hovind, P ;
Tarnow, L ;
Rossing, P ;
Jensen, BR ;
Graae, M ;
Torp, I ;
Binder, C ;
Parving, HH .
BRITISH MEDICAL JOURNAL, 2004, 328 (7448) :1105-1108
[10]   Decreasing incidence of severe diabetic microangiopathy in type 1 diabetes [J].
Hovind, P ;
Tarnow, L ;
Rossing, K ;
Rossing, P ;
Eising, S ;
Larsen, N ;
Binder, C ;
Parving, HH .
DIABETES CARE, 2003, 26 (04) :1258-1264